Difference between revisions of "Team:SHSID/Results"

(Prototype team page)
 
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
{{IGEM_TopBar}}
+
<html lang="en">
{{SHSID}}
+
<html>
+
 
+
<div class="column full_size">
+
<h1>Results</h1>
+
<p>You can describe the results of your project and your future plans here. </p>
+
</div>
+
 
+
 
+
<div class="column third_size" >
+
 
+
<h3>What should this page contain?</h3>
+
<ul>
+
<li> Clearly and objectively describe the results of your work.</li>
+
<li> Future plans for the project. </li>
+
<li> Considerations for replicating the experiments. </li>
+
</ul>
+
</div>
+
 
+
 
+
 
+
 
+
<div class="column two_thirds_size" >
+
<h3>Describe what your results mean </h3>
+
<ul>
+
<li> Interpretation of the results obtained during your project. Don't just show a plot/figure/graph/other, tell us what you think the data means. This is an important part of your project that the judges will look for. </li>
+
<li> Show data, but remember <b>all measurement and characterization data must also be on the Part's Main Page on the <a href="http://parts.igem.org/Main_Page">Registry</a>.</b> Otherwise these data will not be in consideration for any medals or part awards! </li>
+
<li> Consider including an analysis summary section to discuss what your results mean. Judges like to read what you think your data means, beyond all the data you have acquired during your project. </li>
+
</ul>
+
</div>
+
 
+
 
+
<div class="clear extra_space"></div>
+
 
+
 
+
 
+
<div class="column two_thirds_size" >
+
<h3> Project Achievements </h3>
+
 
+
<p>You can also include a list of bullet points (and links) of the successes and failures you have had over your summer. It is a quick reference page for the judges to see what you achieved during your summer.</p>
+
 
+
<ul>
+
<li>A list of linked bullet points of the successful results during your project</li>
+
<li>A list of linked bullet points of the unsuccessful results during your project. This is about being scientifically honest. If you worked on an area for a long time with no success, tell us so we know where you put your effort.</li>
+
</ul>
+
 
+
</div>
+
 
+
 
+
 
+
<div class="column third_size" >
+
<div class="highlight decoration_A_full">
+
<h3>Inspiration</h3>
+
<p>See how other teams presented their results.</p>
+
<ul>
+
<li><a href="https://2019.igem.org/Team:Newcastle/Results">2019 Newcastle</a></li>
+
<li><a href="https://2019.igem.org/Team:Munich/Results">2019 Munich </a></li>
+
<li><a href="https://2019.igem.org/Team:Tec-Chihuahua/Results">2019 Tec Chihuahua</a></li>
+
<li><a href="https://2020.igem.org/Team:Aalto-Helsinki/Results">2020 Aalto Helsinki</a></li>
+
<li><a href="https://2020.igem.org/Team:GreatBay_SCIE/Results">2020 GreatBay SCIE</a></li>
+
<li><a href="https://2020.igem.org/Team:Queens_Canada/Results">2020 Queens Canada</a></li>
+
 
+
</ul>
+
</div>
+
</div>
+
 
+
  
 +
<head>
 +
    <meta charset="UTF-8">
 +
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
 +
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
 +
    <title>SHSID</title>
 +
    <link rel="stylesheet"
 +
        href="https://2021.igem.org/wiki/index.php?title=Template:SHSID/Main_CSS&action=raw&ctype=text/css" />
  
 +
</head>
  
 +
<body>
 +
    <nav class="head-nav clearfix">
 +
        <div class="top-block"></div>
 +
        <div class="top-nav-bar">
 +
            <ul class="clearfix">
 +
                <span class="small-logo"></span>
 +
                <li>
 +
                    <a href="https://2021.igem.org/Team:SHSID">Home</a>
 +
                </li>
 +
                <li class="active">
 +
                    <a href="">Project</a>
 +
                    <div class="sub-nav">
 +
                        <ul>
 +
                            <li><a href="https://2021.igem.org/Team:SHSID/Description"
 +
                                    class="sub-nav-74">Description</a></li>
 +
                            <li><a href="https://2021.igem.org/Team:SHSID/Experiments"
 +
                                    class="sub-nav-74">Experiments</a></li>
 +
                            <li class="current-sub-nav"><a href="#" class="sub-nav-74">Results</a></li>
 +
                            <li><a href="https://2021.igem.org/Team:SHSID/Proof_Of_Concept" class="sub-nav-52">Proof Of
 +
                                    Concept</a></li>
 +
                            <li><a href="https://2021.igem.org/Team:SHSID/Notebook" class="sub-nav-52">Notebook</a></li>
 +
                            <li><a href="https://2021.igem.org/Team:SHSID/Safety">Safety</a></li>
 +
                        </ul>
 +
                    </div>
 +
                </li>
 +
                <li>
 +
                    <a href="">Parts</a>
 +
                    <div class="sub-nav">
 +
                        <ul>
 +
                            <li><a href="https://2021.igem.org/Team:SHSID/Parts" class="sub-nav-74">Parts
 +
                                    Collection</a></li>
 +
                            <li><a href="https://2021.igem.org/Team:SHSID/Engineering"
 +
                                    class="sub-nav-74">Engineering</a></li>
 +
                            <li><a href="https://2021.igem.org/Team:SHSID/Contribution"
 +
                                    class="sub-nav-74">Contribution</a></li>
 +
                        </ul>
 +
                    </div>
 +
                </li>
 +
                <li>
 +
                    <a href="">Human Practices</a>
 +
                    <div class="sub-nav">
 +
                        <ul>
 +
                            <li><a href="https://2021.igem.org/Team:SHSID/Human_Practices" class="sub-nav-74">Integrated
 +
                                    Human Practice</a></li>
 +
                            <li><a href="https://2021.igem.org/Team:SHSID/Communication"
 +
                                    class="sub-nav-74">Communication</a></li>
 +
                            <li><a href="https://2021.igem.org/Team:SHSID/Fundraising"
 +
                                    class="sub-nav-74">Fundraising</a></li>
 +
                        </ul>
 +
                    </div>
 +
                </li>
 +
                <li>
 +
                    <a href="https://2021.igem.org/Team:SHSID/Implementation">Implementation</a>
 +
                </li>
 +
                <li>
 +
                    <a href="https://2021.igem.org/Team:SHSID/Entrepreneurship">Entrepreneurship</a>
 +
                </li>
 +
                <li>
 +
                    <a href="https://2021.igem.org/Team:SHSID/Model">Model</a>
 +
                </li>
 +
                <li>
 +
                    <a href="">Team</a>
 +
                    <div class="sub-nav">
 +
                        <ul>
 +
                            <li><a href="https://2021.igem.org/Team:SHSID/Members" class="sub-nav-74">Team
 +
                                    Members</a></li>
 +
                            <li><a href="https://2021.igem.org/Team:SHSID/Attributions"
 +
                                    class="sub-nav-74">Attributions</a></li>
 +
                            <li><a href="https://2021.igem.org/Team:SHSID/Collaborations"
 +
                                    class="sub-nav-74">Collaborations</a></li>
 +
                        </ul>
 +
                    </div>
 +
                </li>
 +
            </ul>
 +
        </div>
 +
    </nav>
 +
    <div class="sub-content">
 +
        <div class="sub-title">Results</div>
 +
        <div class="article-content" style="text-indent: 30px;">Plasmids containing target genes, AsADC, SPE1, and speB
 +
            are successfully synthesized from 10 DNA segments. Segments 0 to 2 contain promoter PPGK1, target gene
 +
            AsADC, and terminator TADH1. Segments 3 to 5 contain promoter PTEF1, target gene SPE1, and terminator TTEF1.
 +
            Segments 6 to 8 contain promoter PTDH3, target gene speB, and terminator TCYC1. Segment 9 is the backbone
 +
            plasmid pYES2. Transforming this plasmid into yeast will increase the yield of putrescine. </div>
 +
        <div class="article-content" style="padding-left: 30px;box-sizing: border-box;">
 +
            The first round of PCR<br />
 +
            The first round of PCR amplifies DNA segments 0 to 7 separately.
 +
        </div>
 +
        <div class="img-wrap no-margin">
 +
            <img src="https://static.igem.org/mediawiki/2021/6/65/T--SHSID--Results01.png" alt="" />
 +
            <span>Figure 1: Gel electrophoresis diagram. Lane 1 is segment 0. Lane 2 is segment 2. Lane 3 is </span>
 +
        </div>
 +
        <div class="article-content">
 +
            segment 3. Lane 4 is segment 4. Lane 5 is segment 5. Lane 6 is segment 6. Lane 7 is segment 1. Lane 8 is
 +
            segment 7.
 +
        </div>
 +
        <div class="article-content" style="text-indent: 30px;">
 +
            On this gel electrophoresis diagram, all DNA segments were successfully amplified, and the band is on the
 +
            corresponding position to its number of base pairs.
 +
        </div>
 +
        <div class="article-content" style="text-indent: 30px;">
 +
            The second round of PCR
 +
        </div>
 +
        <div class="article-content">
 +
            The second round of PCR overlapped two DNA segments from 0 to 7.
 +
        </div>
 +
        <div class="img-wrap no-margin">
 +
            <img src="https://static.igem.org/mediawiki/2021/2/2d/T--SHSID--Results02.png" alt="" />
 +
        </div>
 +
        <div class="article-content">
 +
            Figure 2: Gel electrophoresis diagram. Lane 1 is segments 0 and 1. Lane 2 is segments 2 and 3. Lane 3 is
 +
            segments 4 and 5. Lane 4 is segments 6 and 7.
 +
        </div>
 +
        <div class="article-content" style="text-indent: 30px;">
 +
            This result shows that the overlap PCR between two DNA segments was successful because the bands are in
 +
            their right position corresponding to the number of base pairs and relative to the ladder.
 +
        </div>
 +
        <div class="article-content" style="padding-left: 30px;box-sizing: border-box;">
 +
            The third round of PCR<br />
 +
            The third round of overlap PCR connects DNA segments 01 with 23, and 45 with 67.
 +
        </div>
 +
        <div class="img-wrap no-margin">
 +
            <img src="https://static.igem.org/mediawiki/2021/7/71/T--SHSID--Results03.png" alt="" />
 +
            <span>Figure 3: Gel electrophoresis diagram. Lane 1 is DNA segments 0 to 3. Lane 2 is DNA segments 4 to 7.
 +
            </span>
 +
        </div>
 +
        <div class="article-content" style="text-indent: 30px;">
 +
            Lane 1 shows a correct and bright band for segments 0 to 3. However, although the band for DNA segments 4 to
 +
            7 in lane 2 has the correct band, the band is very weak, which means that the amount of this segment is not
 +
            enough to carry out the construction of plasmid. This is probably because segments 4 to 7 is longer than
 +
            segments 0 to 3, and the primer is not designed very well. More round of overlap will be needed to obtain
 +
            more segments of 4 to 7.
 +
        </div>
 +
        <div class="article-content" style="text-indent: 30px;">
 +
            The fourth round of PCR
 +
        </div>
 +
        <div class="article-content">
 +
            The fourth round of PCR amplifies segments 8 and 9, and overlapped segments 45 with 67 again.
 +
        </div>
 +
        <div class="img-wrap no-margin">
 +
            <img src="https://static.igem.org/mediawiki/2021/c/c9/T--SHSID--Results04.png" alt="" />
 +
            <span>Figure 4: Gel electrophoresis diagram. Lane 1 to 3 is segments 4567. Lane 4 to 6 is segment 8. Lane 7
 +
                to 9 is segments 9.</span>
 +
        </div>
 +
        <div class="article-content" style="text-indent: 30px;">
 +
            This result shows that the overlap PCR between segments 45 and 67 was successful. The PCR of segment 9 is
 +
            also successful. However, there are no clear bands shown in lane 4 to 6, indicating that the PCR of segment
 +
            8 is not successful.
 +
        </div>
 +
        <div class="article-content" style="text-indent: 30px;">
 +
            Segment 8 was amplified using PCR again.
 +
        </div>
 +
        <div class="img-wrap no-margin">
 +
            <img src="https://static.igem.org/mediawiki/2021/4/47/T--SHSID--Results05.png" alt="" />
 +
            <span>
 +
                Figure 5: Gel electrophoresis diagram. Lane 1 to 3 is segment 8.
 +
            </span>
 +
        </div>
 +
        <div class="article-content" style="text-indent: 30px;">
 +
            This result shows that there are bands on the right position corresponding to the number of base pairs, but
 +
            they are not clear and bright enough. The product of this round of PCR can be used in the construction of
 +
            plasmid.
 +
        </div>
 +
        <div class="article-content" style="text-indent: 30px;">
 +
            The fifth round of PCR
 +
        </div>
 +
        <div class="article-content" style="text-indent: 30px;">
 +
            The fifth round of PCR overlapped segment 67 with 8, and segment 4567 with 8.
 +
        </div>
 +
        <div class="img-wrap no-margin">
 +
            <img src="https://static.igem.org/mediawiki/2021/6/63/T--SHSID--Results06.png" alt="" />
 +
            <span>Figure 6: Gel electrophoresis diagram. Lane 1, 3, 5 are segment 45678. Lane 2, 4, 6 are segment 678.
 +
            </span>
 +
        </div>
 +
        <div class="article-content" style="text-indent: 30px;">
 +
            This figure shows that the overlap PCR of segments 67 and 8 was successful, while segments 4567 and 8 was
 +
            not successful. This is because segment 45678 is too long, which is difficult to carry out accurate overlap
 +
            PCR.
 +
        </div>
 +
        <div class="article-content" style="text-indent: 30px;">
 +
            The sixth round of PCR
 +
        </div>
 +
        <div class="article-content" style="text-indent: 30px;">
 +
            The sixth round of overlap PCR connected segments 4567 with 678, which is a modified version of overlap PCR
 +
            between 4567 and 8 in previous round.
 +
        </div>
 +
        <div class="img-wrap no-margin">
 +
            <img src="https://static.igem.org/mediawiki/2021/d/d3/T--SHSID--Results07.png" alt="" />
 +
            <span>Figure 7: Gel electrophoresis diagram. Lane 1 is segment 45678.</span>
 +
        </div>
 +
        <div class="article-content" style="text-indent: 30px;">
 +
            This result shows that the overlap PCR between segments 4567 and 678 was successful. This is because these
 +
            two segments have more overlapping base pairs, which ensures higher efficiency during overlap PCR.
 +
        </div>
 +
        <div class="article-content" style="text-indent: 30px;">
 +
            Homologous recombination of 0 to 9 fragments
 +
        </div>
 +
        <div class="article-content">
 +
            In order to obtain our target plasmid, there are multi-fragment assembly plan A and B. In plan A, PCR
 +
            amplification products of 0123, 456, 678 and 9 were recovered from gel and the corresponding recombinant
 +
            plasmids were transformed into competent cells for resistance screening of kana. In plan B, the sequence
 +
            fragments were 0123, 4567, 8 and 9. Five single colonies in plan A and one single colony in plan B were
 +
            picked up for further cultivate and plasmid extraction. Identification by electrophoresis showed that
 +
            plasmid 1,4,5 of plan A and 6 of plan B were the candidate with correct size, in which plasmid 5 of plan A
 +
            was confirmed by sequencing.
 +
        </div>
 +
        <div class="img-wrap no-margin">
 +
            <img src="https://static.igem.org/mediawiki/2021/b/b5/T--SHSID--Results08.png" alt="" />
 +
        </div>
 +
        <div class="article-content">
 +
            Figure 8: Gel electrophoresis diagram. Line 1-5 is plasmids 1-5 on plan A plate, in which the size of 1, 4,
 +
            and 5 are correct. Line 6 is plasmid 6 on the plan B plate with correct size. Line 7 is a negative control
 +
            plasmid.
 +
        </div>
 +
        <div class="img-wrap no-margin">
 +
            <img src="https://static.igem.org/mediawiki/2021/4/40/T--SHSID--Results09.jpg" alt="" />
 +
        </div>
 +
        <div class="article-content">
 +
            Figure 9: Blast DNA sequences with theoretical sequences and actual sanger sequencing documents of
 +
            pYES2-ASADC-SPE1-SpeB. The blast result shows that the plasmid is constructed successfully.
 +
        </div>
 +
        <div class="article-content">
 +
            And then, Plasmid 5 was transferred into BY4741 and AQ competent cells. For BY4741, the initial OD600 of
 +
            seed cells was 0.3, and then cells were collected when OD600 reached 0.9 after 3h of culture. The
 +
            transformed plasmid pYES2-ASADC-SPE1-SpeB was cultured on YPD20 with hygromycin B plates for 3 days.
 +
        </div>
 +
        <div class="article-title">
 +
            Fermentation test
 +
        </div>
 +
        <div class="article-content">
 +
            The clones were picked up into YPD20/Hyg test tube for cultivate and activation. In order to observe the
 +
            growth of fermentation strains, we set up negative control and test group, referred as NC and Test,
 +
            respectively. Each of them also includes a putrescine production group referred as NC+Arg*10 and
 +
            Test+Arg*10, respectively, whose medium was supplemented with 10 times Arg.
 +
        </div>
 +
        <div class="img-wrap no-margin">
 +
            <img src="https://static.igem.org/mediawiki/2021/9/9d/T--SHSID--Results10.png" alt="" />
 +
            <span>Figure 10. Growth curve of fermentation strains</span>
 +
        </div>
 +
        <div class="article-content">
 +
            As shown in the figure, the growth trend of the four groups was similar. It took 24 hours to reach the
 +
            stationary phase of growth and this stable period last up to 96 hours. Specifically, the overall growth of
 +
            NC+Arg*10 and Test+Ar*10g group was a little lower than that of NC and Test group perhaps due to the
 +
            pressure of high concentration of Arg.
 +
        </div>
 +
        <div class="article-content">
 +
            At least 3 repeated small-scale metabolite production tests were carried out in YNB-SC medium (containing 10
 +
            times arginine raw material). 2ml supernatant (containing putrescine) of the 48h-metabolites after
 +
            centrifugation were analyzed by LC-MS.
 +
        </div>
 +
        <div class="img-wrap no-margin">
 +
            <img src="https://static.igem.org/mediawiki/2021/1/1c/T--SHSID--Results11.jpg" alt="" />
 +
            <span>
 +
                Figure 11. The peak of putrescine detected by LC-MS.
 +
            </span>
 +
        </div>
 +
        <div class="article-content">
 +
            The results showed that the peak of putrescine appeared at 32 min (as shown in the figure11), indicating
 +
            that the engineered strain we constructed successfully produced putrescine. However, the peak area is small,
 +
            and the output of putrescine is far below the factory mass production level. It is likely that the protein
 +
            expression is insufficient and the metabolic pathway is limited. In the future, the expression of the three
 +
            proteins needs to be further optimized.
 +
        </div>
 +
    </div>
 +
    <footer class="footer">
 +
        <section class="footer-wrap">
 +
            <div class="contact-tips">Follow Us on WeChat and Instagram!</div>
 +
            <img src="https://static.igem.org/mediawiki/2021/5/53/T--SHSID--qrcode.jpg" />
 +
        </section>
 +
    </footer>
 +
</body>
 +
<script>
 +
    let liTags = document.querySelectorAll(".top-nav-bar > ul > li");
 +
    let len = liTags.length;
 +
    for (let i = 0; i < len; i++) {
 +
        liTags[i].onclick = function (e) {
 +
            //先移除所有的点击样式
 +
            for (let j = 0; j < len; j++) {
 +
                liTags[j].classList.remove("active");
 +
            }
 +
            //再添加点击样式
 +
            let li = e.currentTarget;
 +
            li.classList.add("active");
 +
        }
 +
    }
 +
</script>
  
 
</html>
 
</html>

Latest revision as of 17:05, 19 October 2021

SHSID

Results
Plasmids containing target genes, AsADC, SPE1, and speB are successfully synthesized from 10 DNA segments. Segments 0 to 2 contain promoter PPGK1, target gene AsADC, and terminator TADH1. Segments 3 to 5 contain promoter PTEF1, target gene SPE1, and terminator TTEF1. Segments 6 to 8 contain promoter PTDH3, target gene speB, and terminator TCYC1. Segment 9 is the backbone plasmid pYES2. Transforming this plasmid into yeast will increase the yield of putrescine.
The first round of PCR
The first round of PCR amplifies DNA segments 0 to 7 separately.
Figure 1: Gel electrophoresis diagram. Lane 1 is segment 0. Lane 2 is segment 2. Lane 3 is
segment 3. Lane 4 is segment 4. Lane 5 is segment 5. Lane 6 is segment 6. Lane 7 is segment 1. Lane 8 is segment 7.
On this gel electrophoresis diagram, all DNA segments were successfully amplified, and the band is on the corresponding position to its number of base pairs.
The second round of PCR
The second round of PCR overlapped two DNA segments from 0 to 7.
Figure 2: Gel electrophoresis diagram. Lane 1 is segments 0 and 1. Lane 2 is segments 2 and 3. Lane 3 is segments 4 and 5. Lane 4 is segments 6 and 7.
This result shows that the overlap PCR between two DNA segments was successful because the bands are in their right position corresponding to the number of base pairs and relative to the ladder.
The third round of PCR
The third round of overlap PCR connects DNA segments 01 with 23, and 45 with 67.
Figure 3: Gel electrophoresis diagram. Lane 1 is DNA segments 0 to 3. Lane 2 is DNA segments 4 to 7.
Lane 1 shows a correct and bright band for segments 0 to 3. However, although the band for DNA segments 4 to 7 in lane 2 has the correct band, the band is very weak, which means that the amount of this segment is not enough to carry out the construction of plasmid. This is probably because segments 4 to 7 is longer than segments 0 to 3, and the primer is not designed very well. More round of overlap will be needed to obtain more segments of 4 to 7.
The fourth round of PCR
The fourth round of PCR amplifies segments 8 and 9, and overlapped segments 45 with 67 again.
Figure 4: Gel electrophoresis diagram. Lane 1 to 3 is segments 4567. Lane 4 to 6 is segment 8. Lane 7 to 9 is segments 9.
This result shows that the overlap PCR between segments 45 and 67 was successful. The PCR of segment 9 is also successful. However, there are no clear bands shown in lane 4 to 6, indicating that the PCR of segment 8 is not successful.
Segment 8 was amplified using PCR again.
Figure 5: Gel electrophoresis diagram. Lane 1 to 3 is segment 8.
This result shows that there are bands on the right position corresponding to the number of base pairs, but they are not clear and bright enough. The product of this round of PCR can be used in the construction of plasmid.
The fifth round of PCR
The fifth round of PCR overlapped segment 67 with 8, and segment 4567 with 8.
Figure 6: Gel electrophoresis diagram. Lane 1, 3, 5 are segment 45678. Lane 2, 4, 6 are segment 678.
This figure shows that the overlap PCR of segments 67 and 8 was successful, while segments 4567 and 8 was not successful. This is because segment 45678 is too long, which is difficult to carry out accurate overlap PCR.
The sixth round of PCR
The sixth round of overlap PCR connected segments 4567 with 678, which is a modified version of overlap PCR between 4567 and 8 in previous round.
Figure 7: Gel electrophoresis diagram. Lane 1 is segment 45678.
This result shows that the overlap PCR between segments 4567 and 678 was successful. This is because these two segments have more overlapping base pairs, which ensures higher efficiency during overlap PCR.
Homologous recombination of 0 to 9 fragments
In order to obtain our target plasmid, there are multi-fragment assembly plan A and B. In plan A, PCR amplification products of 0123, 456, 678 and 9 were recovered from gel and the corresponding recombinant plasmids were transformed into competent cells for resistance screening of kana. In plan B, the sequence fragments were 0123, 4567, 8 and 9. Five single colonies in plan A and one single colony in plan B were picked up for further cultivate and plasmid extraction. Identification by electrophoresis showed that plasmid 1,4,5 of plan A and 6 of plan B were the candidate with correct size, in which plasmid 5 of plan A was confirmed by sequencing.
Figure 8: Gel electrophoresis diagram. Line 1-5 is plasmids 1-5 on plan A plate, in which the size of 1, 4, and 5 are correct. Line 6 is plasmid 6 on the plan B plate with correct size. Line 7 is a negative control plasmid.
Figure 9: Blast DNA sequences with theoretical sequences and actual sanger sequencing documents of pYES2-ASADC-SPE1-SpeB. The blast result shows that the plasmid is constructed successfully.
And then, Plasmid 5 was transferred into BY4741 and AQ competent cells. For BY4741, the initial OD600 of seed cells was 0.3, and then cells were collected when OD600 reached 0.9 after 3h of culture. The transformed plasmid pYES2-ASADC-SPE1-SpeB was cultured on YPD20 with hygromycin B plates for 3 days.
Fermentation test
The clones were picked up into YPD20/Hyg test tube for cultivate and activation. In order to observe the growth of fermentation strains, we set up negative control and test group, referred as NC and Test, respectively. Each of them also includes a putrescine production group referred as NC+Arg*10 and Test+Arg*10, respectively, whose medium was supplemented with 10 times Arg.
Figure 10. Growth curve of fermentation strains
As shown in the figure, the growth trend of the four groups was similar. It took 24 hours to reach the stationary phase of growth and this stable period last up to 96 hours. Specifically, the overall growth of NC+Arg*10 and Test+Ar*10g group was a little lower than that of NC and Test group perhaps due to the pressure of high concentration of Arg.
At least 3 repeated small-scale metabolite production tests were carried out in YNB-SC medium (containing 10 times arginine raw material). 2ml supernatant (containing putrescine) of the 48h-metabolites after centrifugation were analyzed by LC-MS.
Figure 11. The peak of putrescine detected by LC-MS.
The results showed that the peak of putrescine appeared at 32 min (as shown in the figure11), indicating that the engineered strain we constructed successfully produced putrescine. However, the peak area is small, and the output of putrescine is far below the factory mass production level. It is likely that the protein expression is insufficient and the metabolic pathway is limited. In the future, the expression of the three proteins needs to be further optimized.